Viking Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:VKTX

Comments

Viking Therapeutics Inc Earnings Estimates

VKTXNASDAQ

Trade with Public

$36.01

0.381.07%

At close: Mar 13, 5:00 PM EST

$36.27

0.641.78%

Pre-Market: 5:49 AM EST

Overview NewsEarningsOptions Analyst Ratings Insider Trades Short Interest Stock Report

Viking Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:VKTX

Viking Therapeutics (VKTX) is scheduled to report Q1 earnings on April 22, 2026. Analysts estimate EPS of $-0.98 and quarterly revenue of N/A.

In the most recent quarter (Q4), Viking Therapeutics reported EPS of $-1.38, missing estimates of $-0.90 by 0.53%. Revenue came in at $0.00, missing the estimate of $10.00M by 1.00%.

Viking Therapeutics has missed EPS estimates in 5 consecutive quarters.

Over the last 4 quarters, Viking Therapeutics has averaged an EPS surprise of 0.34% and a revenue surprise of 1.00%.

Earnings Date

Apr 22

EPS Estimate

$-0.980

Quarterly Revenue Estimate

–

Annual Revenue
(as of Dec 31)

–

Viking Therapeutics Earnings History

Analyze the earnings history of Viking Therapeutics using advanced sorting and filters.

Loading calendar...

Viking Therapeutics (VKTX) Earnings Per Share

The chart below shows Viking Therapeutics's reported EPS compared to analyst estimates over recent quarters.

Viking Therapeutics (VKTX) Revenue

The chart below shows Viking Therapeutics's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Viking Therapeutics (NASDAQ:VKTX) reporting earnings?

Viking Therapeutics (VKTX) is scheduled to report earnings on April 22, 2026. The last reported earnings were for reported on February 11, 2026 for Q4.

What were the latest earnings per share (EPS) for Viking Therapeutics (NASDAQ:VKTX)?

The Actual EPS was $-1.38, which missed the estimate of $-0.90.

What were Viking Therapeutics’s (NASDAQ:VKTX) revenues?

The Actual Revenue was $0.00, which missed the estimate of $10.00M.

People Also Watch

IDEAYA Biosciences Inc

Centessa Pharmaceuticals PLC

Xenon Pharmaceuticals Inc

Viking Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:VKTX

Viking Therapeutics (VKTX) is scheduled to report Q1 earnings on April 22, 2026. Analysts estimate EPS of $-0.98 and quarterly revenue of N/A.

In the most recent quarter (Q4), Viking Therapeutics reported EPS of $-1.38, missing estimates of $-0.90 by 0.53%. Revenue came in at $0.00, missing the estimate of $10.00M by 1.00%.

Viking Therapeutics has missed EPS estimates in 5 consecutive quarters.

Over the last 4 quarters, Viking Therapeutics has averaged an EPS surprise of 0.34% and a revenue surprise of 1.00%.

Earnings Date

Apr 22

EPS Estimate

$-0.980

Quarterly Revenue Estimate

–

Annual Revenue
(as of Dec 31)

–